Home/Filings/4/0001209191-23-004874
4//SEC Filing

Tang Carolyn C. 4

Accession 0001209191-23-004874

CIK 0001724521other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 5:52 PM ET

Size

7.1 KB

Accession

0001209191-23-004874

Insider Transaction Report

Form 4
Period: 2023-01-23
Tang Carolyn C.
General Counsel
Transactions
  • Award

    Common Stock

    2023-01-23+34,00097,539 total
  • Award

    Stock Option (right to buy)

    2023-01-23+138,200138,200 total
    Exercise: $22.02Exp: 2033-01-22Common Stock (138,200 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company.
  • [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company.

Issuer

Arcus Biosciences, Inc.

CIK 0001724521

Entity typeother

Related Parties

1
  • filerCIK 0001836662

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 5:52 PM ET
Size
7.1 KB